510(k) Report

FDA applicant

Innovacon, Inc.

San Diego, CA3 decisions2006–200711 recalls

FDA records 3 decisions for Innovacon, Inc. (San Diego, CA) from 2006 to 2007: 3 510(k) clearances. Most are in product codes DKZ (Enzyme Immunoassay, Amphetamine) and KHE (Reagent, Occult Blood). Its devices cite 7 predicates, 0 of them its own earlier devices. 11 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Innovacon, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

1in 2026

2007: 12009: 52011: 12013: 12022: 22026 (partial year): 1
2007high 5 (2009) · low 0 (2008)2026

Class I Class II/III not classified

FIG. 1 — Innovacon, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Innovacon, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report